Wall Street analysts forecast that McKesson Corporation (NYSE:MCK) will announce sales of $51.60 billion for the current quarter, Zacks reports. Five analysts have issued estimates for McKesson Corporation’s earnings, with the highest sales estimate coming in at $51.74 billion and the lowest estimate coming in at $51.45 billion. McKesson Corporation reported sales of $49.96 billion in the same quarter last year, which indicates a positive year over year growth rate of 3.3%. The company is expected to issue its next earnings results on Thursday, October 26th.

On average, analysts expect that McKesson Corporation will report full-year sales of $51.60 billion for the current fiscal year, with estimates ranging from $204.40 billion to $206.70 billion. For the next fiscal year, analysts anticipate that the business will post sales of $209.40 billion per share, with estimates ranging from $202.78 billion to $213.17 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that that provide coverage for McKesson Corporation.

McKesson Corporation (NYSE:MCK) last posted its quarterly earnings data on Thursday, July 27th. The company reported $2.46 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.81 by $0.35. McKesson Corporation had a net margin of 2.42% and a return on equity of 25.76%. The firm had revenue of $51.05 billion for the quarter, compared to the consensus estimate of $51.22 billion. During the same quarter last year, the firm earned $3.50 EPS. The company’s revenue was up 2.7% on a year-over-year basis.

MCK has been the subject of a number of recent research reports. Jefferies Group LLC initiated coverage on McKesson Corporation in a research note on Wednesday, May 17th. They issued a “hold” rating and a $153.00 target price for the company. Vetr raised McKesson Corporation from a “buy” rating to a “strong-buy” rating and set a $181.27 target price for the company in a research note on Monday, June 19th. BidaskClub downgraded McKesson Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. J P Morgan Chase & Co raised McKesson Corporation from a “neutral” rating to an “overweight” rating and set a $189.00 target price for the company in a research note on Tuesday, May 23rd. Finally, Zacks Investment Research raised McKesson Corporation from a “hold” rating to a “buy” rating and set a $184.00 target price for the company in a research note on Wednesday, July 12th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $172.31.

McKesson Corporation (MCK) opened at 156.94 on Friday. McKesson Corporation has a 52-week low of $114.53 and a 52-week high of $181.53. The firm’s 50-day moving average is $153.75 and its 200-day moving average is $152.84. The company has a market cap of $33.00 billion, a PE ratio of 7.12 and a beta of 1.16.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Investors of record on Friday, September 1st will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.87%. This is a boost from McKesson Corporation’s previous quarterly dividend of $0.28. The ex-dividend date is Wednesday, August 30th. McKesson Corporation’s dividend payout ratio (DPR) is 6.07%.

COPYRIGHT VIOLATION WARNING: This news story was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/09/mckesson-corporation-mck-expected-to-post-quarterly-sales-of-51-60-billion.html.

In related news, Director M Christine Jacobs sold 1,083 shares of the firm’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $145.43, for a total transaction of $157,500.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Erin M. Lampert sold 900 shares of the firm’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $155.65, for a total value of $140,085.00. The disclosure for this sale can be found here. Insiders have sold a total of 3,066 shares of company stock valued at $473,627 over the last 90 days. 1.20% of the stock is currently owned by company insiders.

A number of institutional investors have recently made changes to their positions in MCK. BlackRock Inc. boosted its holdings in McKesson Corporation by 2,026.2% during the 1st quarter. BlackRock Inc. now owns 14,198,977 shares of the company’s stock valued at $2,105,140,000 after acquiring an additional 13,531,173 shares during the period. Ballentine Partners LLC purchased a new position in McKesson Corporation during the 1st quarter valued at about $191,000. Parnassus Investments CA boosted its holdings in McKesson Corporation by 310.0% during the 1st quarter. Parnassus Investments CA now owns 4,280,594 shares of the company’s stock valued at $620,727,000 after acquiring an additional 3,236,594 shares during the period. Pzena Investment Management LLC boosted its holdings in McKesson Corporation by 1,015.0% during the 1st quarter. Pzena Investment Management LLC now owns 2,077,104 shares of the company’s stock valued at $307,951,000 after acquiring an additional 1,890,815 shares during the period. Finally, Ameriprise Financial Inc. boosted its holdings in McKesson Corporation by 288.6% during the 1st quarter. Ameriprise Financial Inc. now owns 1,752,850 shares of the company’s stock valued at $259,883,000 after acquiring an additional 1,301,803 shares during the period. Institutional investors own 85.28% of the company’s stock.

About McKesson Corporation

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

Get a free copy of the Zacks research report on McKesson Corporation (MCK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for McKesson Corporation (NYSE:MCK)

Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with MarketBeat.com's FREE daily email newsletter.